Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

6.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.1K
Liver Regeneration01:24

Liver Regeneration

5.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
5.3K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

3
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
3
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

3
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
3

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Titanium dioxide nanoparticles relieve biochemical dysfunctions of fifth-instar larvae of silkworms following exposure to phoxim insecticide.

Chemosphere·2012
Same author

Mechanisms of prostate atrophy after LHRH antagonist cetrorelix injection: an experimental study in a rat model of benign prostatic hyperplasia.

Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban·2012
Same author

Simulation and experimental investigation of structural dynamic frequency characteristics control.

Sensors (Basel, Switzerland)·2012
Same author

Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression.

Journal of affective disorders·2012
Same author

Application of nanoLC-MS/MS to the shotgun proteomic analysis of the nematocyst proteins from jellyfish Stomolophus meleagris.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2012
Same author

Identification of Sare0718 as an alanine-activating adenylation domain in marine actinomycete Salinispora arenicola CNS-205.

PloS one·2012

Related Experiment Video

Updated: Apr 18, 2026

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy
05:20

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Published on: June 29, 2021

3.6K

Mesenchymal stem cells mitigate cirrhosis through BMP7.

Bing Li1, Qing Shao, Dong Ji

  • 1Liver Fibrosis Diagnosis and Treatment Center, 302 Hospital of PLA, Beijing, China.

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|January 24, 2015
PubMed
Summary

Mesenchymal stem cell (MSC) transplantation alleviates carbon tetrachloride-induced liver cirrhosis in mice. This therapeutic effect is mediated by bone morphogenic protein 7 (BMP7), which counteracts the fibrogenic transforming growth factor beta 1 (TGFβ1).

More Related Videos

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
12:06

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

22.9K
Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
10:18

Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo

Published on: September 11, 2018

6.3K

Related Experiment Videos

Last Updated: Apr 18, 2026

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy
05:20

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Published on: June 29, 2021

3.6K
Isolation of CD133+ Liver Stem Cells for Clonal Expansion
12:06

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

22.9K
Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
10:18

Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo

Published on: September 11, 2018

6.3K

Area of Science:

  • Hepatology
  • Stem Cell Biology
  • Fibrosis Research

Background:

  • Mesenchymal stem cells (MSCs) show therapeutic potential across diseases.
  • The role and mechanism of MSCs in cirrhosis development and treatment were largely unexplored.

Purpose of the Study:

  • To investigate the therapeutic effect of MSCs on developing cirrhosis.
  • To elucidate the underlying molecular mechanisms, focusing on TGFβ1 and BMP7.

Main Methods:

  • Carbon tetrachloride (CCl4) was used to induce cirrhosis in C57BL/6 mice.
  • Mice received MSC transplantation or saline control, followed by evaluation of liver fibrosis, portal pressure, and sodium balance.
  • Gene expression of TGFβ1 and BMP7 was quantified; BMP7-depleted MSCs were also tested.

Main Results:

  • MSC transplantation significantly alleviated liver fibrosis, portal hypertension, and sodium retention.
  • MSCs decreased TGFβ1 and increased BMP7 levels in injured livers.
  • BMP7 expression by MSCs was crucial, as BMP7 depletion abolished their protective effects.

Conclusions:

  • MSCs mitigate cirrhosis by producing BMP7, which antagonizes the fibrogenic effects of TGFβ1.
  • BMP7 is a key mediator of MSCs' protective action against liver fibrosis.